Suppr超能文献

**摘要**:保乳术后放疗对胸肌前假体植入乳房重建结局的影响:一项系统评价和荟萃分析。

The Impact of Postmastectomy Radiation Therapy on the Outcomes of Prepectoral Implant-Based Breast Reconstruction: A Systematic Review and Meta-Analysis.

机构信息

Department of Plastic and Reconstructive Surgery, Faculty of Medicine (Boys), Al-Azhar University, Al Mokhaym Al Daem, Gameat Al Azhar, Nasr City, Cairo, Egypt.

Department of Plastic and Reconstructive Surgery, El-Sahel Teaching Hospital, Cairo, Egypt.

出版信息

Aesthetic Plast Surg. 2023 Feb;47(1):81-91. doi: 10.1007/s00266-022-03026-y. Epub 2022 Jul 25.

Abstract

BACKGROUND

Breast reconstruction is the mainstay treatment choice for patients subjected to a mastectomy. Prepectoral implant-based breast reconstruction (IBBR) is deemed to be a promising alternative to subpectoral reconstruction. Postmastectomy radiation therapy (PMRT) is necessary for locoregional recurrence control and to improve the disease-free survival rate in locally advanced breast cancer. This systematic review and meta-analysis study was designed to reveal the surgical, aesthetic, and oncological outcomes of prepectoral IBBR after PMRT.

METHODS

An extensive literature search was performed from inception to March 28, 2022. All clinical studies that included patients who were subjected to prepectoral IBBR and PMRT were included. Studies that included patients who received radiation therapy before prepectoral IBBR were excluded.

RESULTS

This systematic review included six articles encompassing 1234 reconstructed breasts. Of them, 391 breasts were subjected to PMRT, while 843 breasts were not subjected. Irradiated breasts were more susceptible to develop wound infection (RR 2.49; 95% 1.43, 4.35; P = 0.001) and capsular contracture (RR 5.17; 95% 1.93, 13.80; P = 0.001) than the non-irradiated breasts. Furthermore, irradiated breasts were more vulnerable to losing implants (RR 2.89; 95% 1.30, 6.39; P = 0.009) than the non-irradiated breast. There was no significant difference between both groups regarding the risk of implant extrusion (RR 1.88; 95% 0.20, 17.63; P = 0.58).

CONCLUSIONS

Patients with prepectorally IBBR and PMRT were more vulnerable to developing poor outcomes. This included a higher risk of breast-related and implant-related adverse events.

LEVEL OF EVIDENCE III

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

摘要

背景

乳房重建是接受乳房切除术的患者的主要治疗选择。胸肌前植入物乳房重建(IBBR)被认为是胸肌后重建的一种有前途的替代方法。乳腺癌根治术后放疗(PMRT)是局部区域复发控制和提高局部晚期乳腺癌无病生存率所必需的。本系统评价和荟萃分析旨在揭示 PMRT 后胸肌前 IBBR 的手术、美容和肿瘤学结果。

方法

从成立到 2022 年 3 月 28 日进行了广泛的文献检索。纳入了所有纳入接受胸肌前 IBBR 和 PMRT 的患者的临床研究。排除了接受胸肌前 IBBR 前接受放疗的患者的研究。

结果

本系统评价纳入了 6 篇文章,共包括 1234 例重建乳房。其中 391 例乳房接受 PMRT,843 例乳房未接受 PMRT。接受放疗的乳房更容易发生伤口感染(RR 2.49;95% 1.43,4.35;P=0.001)和包膜挛缩(RR 5.17;95% 1.93,13.80;P=0.001),而非接受放疗的乳房。此外,接受放疗的乳房更容易失去植入物(RR 2.89;95% 1.30,6.39;P=0.009),而非接受放疗的乳房。两组之间的植入物挤出风险无显著差异(RR 1.88;95% 0.20,17.63;P=0.58)。

结论

接受胸肌前 IBBR 和 PMRT 的患者更容易出现不良结局。这包括乳房相关和植入物相关不良事件的风险增加。

证据水平 III:本杂志要求作者为每篇文章分配一个证据水平。有关这些循证医学评级的完整描述,请参考目录或在线作者指南 www.springer.com/00266

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a795/9945051/59d3897dec12/266_2022_3026_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验